ICOS CORPORATION
ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in the commercialization of treatments for unmet medical conditions, such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer, and inflammatory diseases. It is the developer of a treatment known as Cialis (tadalafil), a product for the treatment of erectile dysfunction through its joint venture with Eli Lilly and C... ompany in North America and Europe. It is also engaged in contract manufacturing services for third parties. It is in a strategic alliance with Solvay Pharmaceuticals, Inc. ICOS Corporation was established in 1989, based in Bothell, Washington. It is currently operated by Eli Lilly and Company.
ICOS CORPORATION
Industry:
Biotechnology Health Care
Founded:
1989-01-01
Status:
Active
Total Funding:
0
Similar Organizations
TransTech Pharma
TransTech Pharma is engaged in the discovery, development, and commercialization of human therapeutics.
Investors List
CHL Medical Partners
CHL Medical Partners investment in Venture Round - ICOS Corporation
More informations about "ICOS Corporation"
ICOS Corporation - Crunchbase Company Profile
ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. It is engaged in …See details»
Press Release: Eli Lilly Announces Revised Merger Agreement With …
Dec 17, 2006 About ICOS Corporation: ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to …See details»
Eli Lilly and Company Announces Completion Of ICOS Corporation ...
Jan 30, 2007 Actual results may differ materially and will depend on, among other things, realization of anticipated operational efficiencies following the merger with ICOS; the …See details»
ICOS Corporation Company Profile | Bothell, WA | Competitors ...
Find company research, competitor information, contact details & financial data for ICOS Corporation of Bothell, WA. Get the latest business insights from Dun & Bradstreet.See details»
ICOS Corporation - Funding, Financials, Valuation & Investors
Dec 31, 1990 ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. New. Resources. ... How much …See details»
ICOS Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ICOS Corp. with its drug pipeline, therapeutic area, technology platform, 26 clinical trials, 6 news, and 273 literature, Disease Domain:Neoplasms, Technology Platform:Chemical …See details»
ICOS Corporation - Crunchbase
ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. ... Experience the new Crunchbase, powered by AI …See details»
Organization | ICOS - Purdue University
Organization Overview. First Clinical Trial. 1996 Unregistered Trial 1. First Marketed Drug. None First NDA Approval. None ... ICOS Corporation | ICOS-Texas Biotechnology Active …See details»
ICOS - Ownership and Business Overview - Mergr
ICOS Corp. 22021 20th Avenue SE, Bothell, Washington 98021 United States, (425) 485-1900 www.ICOS.com. Profile Investors (1) Analytics ICOS Corp. a biotechnology company based in …See details»
ICOS Corp. (ICOS Corp.) - 药物管线_专利_临床试验_投融营收_最新 …
了解ICOS Corp. (ICOS Corp.)公司的药物管线，治疗领域，技术平台，以及它的26项临床试验, 6篇新闻和272篇文献，疾病领域:肿瘤，技术平台:化学药，小分子化药，药 …See details»
ICOS Corp.:Company Profile & Technical Research,Competitor …
ICOS Corp. is a company that provides Biotechnology, Medicine, Biomanufacturing and more. ICOS Corp. is headquartered in United States Washington. ICOS Corp. was founded in 1989. …See details»
ICOS 2025 Company Profile: Valuation, Investors, Acquisition
When was ICOS founded? ICOS was founded in 1989. Where is ICOS headquartered? ICOS is headquartered in Bothell, WA. What is the size of ICOS? ICOS has 700 total employees. What …See details»
ICOS Corp. - Drug pipelines, Patents, Clinical trials - Synapse
Explore ICOS Corp. with its drug pipeline, therapeutic area, technology platform, 26 clinical trials, 6 news, and 427 literature, Disease Domain:Neoplasms, Technology Platform:Chemical …See details»
Icos Corp : ICOS Corporation Announces Agreement to be …
Oct 17, 2006 About ICOS Corporation: ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to …See details»
Working At Icos: Company Overview and Culture - Zippia
Organization Type. Public. CEO. Paul Clark. Icos Corporation was an American biotechnology company and the largest biotechnology company in the U.S. state of Washington, before it …See details»
ICOS-ICOS Corporation-企业详情-InvestGO数据库-ByDrug-医药魔 …
查看医药魔方InvestGO®数据库ICOS的公司信息。ICOS（ICOS Corporation），公司简介：ICOS Corporation is a biotechnology company that engages in the discovery, development, and …See details»
Lilly acquires ICOS Corporation for $2.1 Billion - chemeurope.com
Oct 19, 2006 Eli Lilly and Company announced that it has signed a definitive merger agreement to acquire ICOS Corporation in a cash transaction. Under the terms of the agreement, Lilly will …See details»
ICOS Corporation - Tech Stack, Apps, Patents & Trademarks
ICOS Corporation is a biotechnology company that engages in the discovery, development, and commercialization of therapeutic products. New. ... Experience the new Crunchbase, powered …See details»
Initial Coin Offerings (ICOs) Explained | Coindoo
The legal paperwork for setting up a corporation, a holding account, or a term sheet is costly. Having investors read all that material before signing on is usually lengthy. With ICOs, there …See details»